Complex regional pain syndrome type I: Efficacy of stellate ganglion blockade

被引：61

作者：

Yucel I. ^{[1
]}

Demiraran Y. ^{[2
]}

Ozturan K. ^{[3
]}

Degirmenci E. ^{[4
]}

机构：

[1] Department of Orthopaedics and Traumatology, Faculty of Medicine, University of Duzce, Duzce

[2] Department of Anaesthesiology, Faculty of Medicine, University of Duzce, Duzce

[3] Department of Orthopaedics and Traumatology, Faculty of Medicine, University of Abant Izzet Baysal, Bolu

[4] Orthopaedics and Traumatology Clinic, Yuksekova State Hospital, Hakkari

来源：

Journal of Orthopaedics and Traumatology | 2009年 / 10卷 / 4期

关键词：

Complex regional pain syndrome type I; Stellate ganglion blockade; VAS; Wrist range of motion;

D O I：

10.1007/s10195-009-0071-5

中图分类号：

学科分类号：

摘要：

Background: This study was performed to evaluate the treatment of complex regional pain syndrome (CRPS) type I with stellate ganglion blockade. Materials and methods: We performed three blockades at weekly intervals in 22 patients with CRPS type I in one hand. The patients were divided into two groups depending on the time between symptom onset and treatment initiation. Group 1and 2 patients had short and long symptom-onset-to-treatment intervals, respectively. Pain intensity, using a visual analog score (VAS), and range of motion (ROM) for the wrist joint were assessed before and 2 weeks after treatment and were compared using nonparametric statistical analysis. Results: Treatment produced a statistically significant difference in wrist ROM for all patients (P < 0.001). VAS values showed an overall decrease from 8 ± 1 to 1 ± 1 following treatment, and there was a significant difference in VAS value between groups 1 and 2 (P < 0.05). Conclusions: We concluded that stellate ganglion blockade successfully decreased VAS and increased ROM of wrist joints in patients with CRPS type I. Further, the duration between symptom onset and therapy initiation was a major factor affecting blockade success. © 2009 Springer-Verlag.

引用

页码：179 / 183

页数：4

共 21 条

[1]

Rowbotham M.C., Pharmacologic management of complex regional pain syndrome, Clinical Journal of Pain, 22, 5, pp. 425-429, (2006)

[2]

Merskey H., Bogduk N., Classification of Chronic Pain, pp. 40-43, (1994)

[3]

Kingery W.S., A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes, Pain, 73, 2, pp. 123-139, (1997)

[4]

CRPS: Current Diagnosis and Therapy, pp. 45-58, (2005)

[5]

Nelson D.V., Stacey B.R., Interventional therapies in the management of complex regional pain syndrome, Clinical Journal of Pain, 22, 5, pp. 438-442, (2006)

[6]

Cepeda M.S., Carr D.B., Lau J., Local anesthetic sympathetic blockade for complex regional pain syndrome, Cochrane Database Syst Rev, 19, (2005)

[7]

Stanton-Hicks M.D., Burton A.W., Bruehl S.P., Carr D.B., Harden R.N., Hassenbusch S.J., Et al., An updated interdisciplinary clinical pathway for CRPS: Report of an expert panel, Pain Pract, 2, pp. 1-16, (2002)

[8]

Stanton-Hicks M., Janig W., Hassenbusch S., Haddox J.D., Boas R., Wilson P., Reflex sympathetic dystrophy: Changing concepts and taxonomy, Pain, 63, pp. 127-133, (1995)

[9]

Dunningham T.H., The treatment of Sudeck's atrophy in the upper limb by sympathetic blockade, Injury, 12, 2, pp. 139-144, (1980)

[10]

Hempel V., The stellate ganglion blockade, Anaesthesist, 42, pp. 119-128, (1993)

← 1 2 3 →